Paclitaxel neurotoxicity
WebJan 1, 2014 · Although it is generally assumed that paclitaxel's neurotoxicity is directly due to its effect on microtubules, the possibility remains that it is due to an off-target effect, or that an off-target effect also contributes to the pathogenesis. WebMar 9, 2010 · Neurotoxicity is one of the most relevant dose-limiting toxicities of the anticancer drug paclitaxel. It exhibits substantial interindividual variability of unknown molecular basis, and represents ...
Paclitaxel neurotoxicity
Did you know?
WebThieme E-Books & E-Journals. Literatur; Einleitung Die chemotherapie-induzierte Polyneuropathie (CIPNP) ist eine der Hauptnebenwirkungen bei der Anwendung taxanhaltiger Chemotherapien. Die Patient:innen berichten über sensorische und motorische Störungen, die häufig dazu führen, dass aufgrund der Nebenwirkungen eine … WebMay 1, 2006 · Because paclitaxel promotes microtubule assembly, neurotoxicity is one of its side effects. Clinical use of paclitaxel has led to peripheral neuropathy and this has been demonstrated to be...
WebPatients who experience severe neutropenia (neutrophil <500 cells/mm 3 for a week or longer) or severe peripheral neuropathy during Paclitaxel Injection, USP therapy should have dosage reduced by 20% for subsequent courses of paclitaxel. The incidence of neurotoxicity and the severity of neutropenia increase with dose. WebSep 4, 2024 · Brief Summary: Taxane-induced peripheral neuropathy (TIPN) caused by albumin-bound paclitaxel is a dose-limiting toxicity. The main symptoms of discomfort are numbness, tingling, and burning sensations in the glove-sock-like distribution of the limbs.
WebDec 5, 2011 · Paclitaxel exerts its antitumor activity by promoting microtubule assembly and stabilizing microtubules. Microtubules are important for the development and … WebAug 26, 2024 · Neurotoxicity is one of the most common non-haematological adverse events of oxaliplatin treatment, affecting up to 84.5% of patients [ 16] and a leading cause for treatment modification including dose reduction, delay, or treatment cessation [ 17 ].
WebSep 16, 2024 · Paclitaxel was used as a proxy for both drugs as dose adjustments for paclitaxel were typically similar or larger than carboplatin. Reduction of cumulative dose …
WebMar 9, 2010 · Neurotoxicity is one of the most relevant dose-limiting toxicities of the anticancer drug paclitaxel. It exhibits substantial interindividual variability of unknown … companies and their taglineWebFeb 15, 2024 · This cohort study of patients with cancer treated with paclitaxel or oxaliplatin assesses blood-based and clinical factors associated with chemotherapy-induced ... Kwok JB, Asher R, et al. Clinical and genetic predictors of paclitaxel neurotoxicity based on patient- versus clinician-reported incidence and severity of neurotoxicity in the ... companies and their information systemscompanies and their target marketWebFeb 16, 2024 · The final concentrations of paclitaxel that cause neurotoxicity but do not affect cell viability were determined to be 1, 10, and 100 ng/ml. In addition, the concentrations of TMI-1 were optimized to 0.04, 0.4, and 4 ng/ml. Effects of TMI-1 on the Neurite Growth of 50B11 Cells Treated With Paclitaxel eating out is such a pleasureWebFeb 1, 2024 · The neurotoxicity of epothilone B and paclitaxel correlates with their microtubule stabilization As a first step in defining mechanistic pathways that lead to paclitaxel neurotoxicity, we tested the hypothesis that increased microtubule stability, rather than off-target effects, is the primary cause of paclitaxel neurotoxicity. companies announcing bonus shares in 2022WebThe widely used chemotherapeutic paclitaxel causes CIPN, which involves degeneration of sensory axons in the skin and loss of sensation and ongoing pain in the hands and feet. Paclitaxel is known to bind and stabilize microtubules, but the cellular mechanisms that underlie paclitaxel’s neurotoxic effects are not well understood. eating out is a waste of moneyWebJun 23, 2024 · Detailed Paclitaxel dosage information for adults. Includes dosages for Breast Cancer, Non-Small Cell Lung Cancer, Breast Cancer - Adjuvant and more; plus … companies animal testing